Abstract
Background: It is known that an increased oxidative stress is present in a wide range of diseases and, given the vulnerability of the central nervous system, its involvement has been in particular investigated in neurological and psychiatric diseases, including anxiety disorders.
Objective: In this review, we analyse the studies that have been conducted on the effects of oxidative stress modulators in anxiety, focusing on their possible clinical use.
Discussion and Conclusion: While preclinical studies have shown a clear anxiolytic-like effect of different oxidative stress modulators, less significant results have been obtained from clinical studies. After having reviewed the possible reasons for the discrepancy between preclinical and clinical data, we encourage further studies aimed at better investigating the utility of the modulation of oxidative stress in humans, as an adjunctive therapy of the traditional integrated psychotherapeutic and pharmacological approach.
Keywords: Oxidative stress modulators, anxiety disorders, anxiety models, reactive oxygen species, reactive nitrogen species, lipid peroxidation.
Current Drug Targets
Title:Potential Use of Modulators of Oxidative Stress as Add-on Therapy in Patients with Anxiety Disorders
Volume: 19 Issue: 6
Author(s): Paolo Boldrini*, Antonella Fusco, Ferdinando Nicoletti, Aldo Badiani and Luciano Saso
Affiliation:
- Department of Physiology and Pharmacology ,Italy
Keywords: Oxidative stress modulators, anxiety disorders, anxiety models, reactive oxygen species, reactive nitrogen species, lipid peroxidation.
Abstract: Background: It is known that an increased oxidative stress is present in a wide range of diseases and, given the vulnerability of the central nervous system, its involvement has been in particular investigated in neurological and psychiatric diseases, including anxiety disorders.
Objective: In this review, we analyse the studies that have been conducted on the effects of oxidative stress modulators in anxiety, focusing on their possible clinical use.
Discussion and Conclusion: While preclinical studies have shown a clear anxiolytic-like effect of different oxidative stress modulators, less significant results have been obtained from clinical studies. After having reviewed the possible reasons for the discrepancy between preclinical and clinical data, we encourage further studies aimed at better investigating the utility of the modulation of oxidative stress in humans, as an adjunctive therapy of the traditional integrated psychotherapeutic and pharmacological approach.
Export Options
About this article
Cite this article as:
Boldrini Paolo *, Fusco Antonella , Nicoletti Ferdinando , Badiani Aldo and Saso Luciano, Potential Use of Modulators of Oxidative Stress as Add-on Therapy in Patients with Anxiety Disorders, Current Drug Targets 2018; 19 (6) . https://dx.doi.org/10.2174/1389450118666170425153356
DOI https://dx.doi.org/10.2174/1389450118666170425153356 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Association between HbA1c Levels, Olfactory Memory and Cognition in Normal, Pre-Diabetic and Diabetic Persons
Endocrine, Metabolic & Immune Disorders - Drug Targets Syntheses, Transformations and Pharmaceutical Applications of Kynurenic Acid Derivatives
Current Medicinal Chemistry Neuroprotective Strategies for Parkinsons Disease
Current Neuropharmacology Functional Interactions of Tau and their Relevance for Alzheimers Disease
Current Alzheimer Research Meet Our Editorial Board Member:
CNS & Neurological Disorders - Drug Targets Role of Molecular Hydrogen in Skin Diseases and its Impact in Beauty
Current Pharmaceutical Design Chronic Myelogenous Leukemia
Current Cancer Therapy Reviews Subject Index To Volume 6
Current Gene Therapy Heart Rate as a Therapeutic Target in Angina Pectoris
Current Pharmaceutical Design Positron Emission Tomography and Autoradiography Imaging of P-selectin Activation Using 68Ga-Fucoidan in Photothrombotic Stroke
Current Neurovascular Research The Potential Effect of Fluorinated Compounds in the Treatment of Alzheimer’s Disease
Current Pharmaceutical Design HER-2 Positive Breast Cancer: What Else Beyond Trastuzumab-Based Therapy?
Anti-Cancer Agents in Medicinal Chemistry Mechanisms of Sleep-Wake Cycle Modulation
CNS & Neurological Disorders - Drug Targets Immunotoxicity of Cocaine and Crack
Current Drug Abuse Reviews Memapsin 2 (Beta-Secretase) Inhibitor Drug, between Fantasy and Reality
Current Alzheimer Research Lack of Association Between Prokineticin 2 Gene and Japanese Methamphetamine Dependence
Current Neuropharmacology Amyloid Beta Peptide 1-40 Stimulates the Na+ / Ca2+ Exchange Activity of SNCX
Current Neurovascular Research Review and Research on Feature Selection Methods from NMR Data in Biological Fluids. Presentation of an Original Ensemble Method Applied to Atherosclerosis Field
Current Drug Metabolism Rational Targeting of Peroxisome Proliferating Activated Receptor Subtypes
Current Medicinal Chemistry Microglia in Alzheimer’s Disease
Current Alzheimer Research